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Abstract
Aims/hypothesis Patients with diabetes mellitus have an
increased risk of stroke and other cerebrovascular compli-
cations. The purpose of this study was to evaluate the
autoregulation of cerebral blood flow in diabetic patients
using a simple method that could easily be applied to the
clinical routine screening of diabetic patients.
Methods We studied ten patients with type 2 diabetes
mellitus and 11 healthy volunteer control participants.
Continuous and non-invasive measurements of blood
pressure and cerebral blood flow velocity were performed
during deep breathing at 0.1 Hz (six breaths per minute).
Cerebral autoregulation was assessed from the phase shift
angle between breathing-induced 0.1 Hz oscillations in
mean blood pressure and cerebral blood flow velocity.
Results The controls and patients all showed positive phase
shift angles between breathing-induced 0.1 Hz blood pres-
sure and cerebral blood flow velocity oscillations. However,
the phase shift angle was significantly reduced (p<0.05)
in the patients (48±9°) compared with the controls (80±12°).
The gain between 0.1 Hz oscillations in blood pressure and
cerebral blood flow velocity did not differ significantly
between the patients and controls.
Conclusions/interpretation The reduced phase shift angle
between oscillations in mean blood pressure and cerebral
blood flow velocity during deep breathing suggests altered
cerebral autoregulation in patients with diabetes and might
contribute to an increased risk of cerebrovascular disorders.
Keywords Autonomic nervous system . Blood pressure
regulation . Cerebral autoregulation . Diabetes .
Heart rate variability
Abbreviation
CBFV cerebral blood flow velocity
Introduction
Patients with diabetes mellitus have an increased risk of
cerebrovascular complications, including stroke [1–3]. The
association between diabetes and stroke is probably related,
at least in part, to impaired nitric oxide synthase-dependent
responses of cerebral blood vessels [4, 5]. An additional risk
factor contributing to the incidence of strokes in diabetic
patients is cardiovascular autonomic neuropathy, which is a
common complication of diabetes mellitus and is itself
associated with increased morbidity and mortality [6, 7].
Cerebral autoregulation is the phenomenon by which
cerebral blood flow remains near-constant despite changes
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in systemic blood pressure, provided that mean blood pres-
sure remains within certain limits, usually 50–150 mmHg
[8]. Vascular dysfunction and autonomic neuropathy are
likely to contribute to compromised cerebral autoregulation
in patients with type 2 diabetes, thereby enhancing the risk
of cerebrovascular complications [9]. Testing of cerebral
autoregulation is often performed by measuring responses
of the cerebral blood vessels to blood pressure changes
induced either by pharmacological (e.g. phenylephrine infu-
sion) or mechanical (e.g. release of a thigh cuff) means [10].
In a previous study we assessed cerebral autoregulation in
diabetic patients by mechanically stimulating the carotid
baroreceptors using oscillatory neck suction [11]. We
demonstrated that, during neck suction, the patients showed
a decreased phase relationship between fluctuations in blood
pressure and cerebral blood flow velocity (CBFV), suggest-
ing altered cerebral autoregulation [11]. While techniques
such as neck suction are useful research tools for studying
cardiovascular and cerebrovascular regulation, their clinical
application is somewhat limited, largely as a result of the
specialised equipment involved, as well as the complex
analysis techniques required. An alternative and simple
method of measuring cerebral autoregulation was introduced
by Diehl et al. [12]. Their technique involves generating
sinusoidal oscillations in blood pressure by slow breathing at
six breaths per minute (0.1 Hz). In healthy individuals these
oscillations in blood pressure are transmitted to the cerebral
blood flow but shifted to the left with a phase angle of about
70° [12]. In patients with known autoregulatory disturbances
this phase shift angle is reduced, suggesting a more passive
transfer of blood pressure fluctuations onto the cerebral
vasculature [12]. This technique of assessing cerebral
autoregulation requires no specialised equipment for induc-
ing blood pressure changes and relies only on the patient’s
ability to breathe slowly and deeply. As such, it is a
potentially useful method for clinical application in diabetic
patients who might have subtle cerebrovascular disturbances.
The aim of this study was to evaluate the slow breathing
method as a clinical test of autoregulation in type 2 diabetic
patients. We hypothesised that diabetic patients would show
a reduction in the phase shift between 0.1 Hz breathing-
induced oscillations in blood pressure and CBFV, indicating
impaired cerebral autoregulation.
Methods
We studied ten patients (two women, eight men), aged 58±2
years, who had a confirmed diagnosis of type 2 diabetes
mellitus according to the criteria of the American Diabetes
Association and the World Health Organization. Their
average height was 173±3 cm, average weight 87±6 kg
and BMI 28.8±1.7 kg/m2. Their mean duration of diabetes
was 79±16 months. Five patients were being treated with
insulin and seven patients were on oral glucose-lowering
drugs such as sulfonylureas or metformin. At the time of
testing, the HbA1c levels of the patients ranged from 6.3% to
7.7%, while blood glucose ranged from 5.1 to 6.7 mmol/l.
All patients underwent a battery of standard cardiovascular
reflex tests, including assessment of heart rate variability at
rest and during metronomic breathing, the Valsalva ma-
noeuvre and active standing [13]. Based on these tests, six
of the patients fulfilled the criteria of cardiovascular auto-
nomic neuropathy (defined as two or more abnormal test
results). None of the patients, however, showed any overt
symptoms or signs of diabetic neuropathy. For 24 h prior to
testing, all patients self-monitored their blood glucose at
least three times 1h after meals. The postprandial blood
glucose levels were all below 7.8 mmol/l.
We also tested 11 healthy controls (four women and
seven men). Their average age was 54±3 years, average
height 168±2 cm, average weight 76±5 kg and average
BMI 26.6±1.3 kg/m2. The controls were recruited among
healthy friends or relatives of staff members and patients.
None of the participants (patients and controls) had a
history of chronic alcohol abuse, carcinoma, myopathy,
hyper- or hypothyroidism, arterial hypertension, cardiac
arrhythmia, diagnosed atherosclerosis, previous organ
transplantation, renal disease or any other condition that
would interfere with their ability to participate in the study.
Apart from insulin or glucose-lowering drugs in the
diabetic patients, none of the participants was on any other
medication known to affect cardiovascular or autonomic
regulation. All participants were asked not to consume
nicotine, caffeine or alcohol for 24 h before the experiments
and were studied at least 4 h after consuming a light meal.
The study was carried out in accordance with the
Declaration of Helsinki and its design was approved by
the University of Erlangen-Nuremberg Ethics Committee.
Written informed consent was obtained from each study
participant.
Procedure The tests were performed in a quiet, temperature-
controlled (24°C) room. The patients and controls were
studied in a supine position. Instrumentation for beat-to-beat
cardiovascular and cerebrovascular monitoring was attached
and the measurements were started after about 45 min once
the signals had stabilised. The patients and controls were
then instructed to breathe deeply for 3 min at the rate of six
breaths per minute (5 s inspiration and 5 s expiration) by
following combined visual and auditory stimuli. This stan-
dard challenge manoeuvre induces sinusoidal oscillations in
arterial blood pressure and CBFV at a frequency of 0.1 Hz
(six per minute) [12].
We continuously monitored the electrocardiographic RR
intervals and non-invasive beat-to-beat blood pressure at
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the left radial artery using applanation tonometry calibrated
by a brachial blood pressure cuff (Colin Pilot; Colin
Medical, San Antonio, TX, USA). Respiratory frequency
was monitored by calibrated electrical inductance plethys-
mography (Respitrace Calibrator; Ambulatory Monitoring,
Ardsley, NY, USA) with two respiratory belts placed
around the chest and abdomen.
We recorded CBFV using transcranial Doppler ultraso-
nography (Multidop XL; DWL, Sipplingen, Germany) at
the proximal segment of the middle cerebral artery, in-
sonated through the temporal window approximately 1 cm
above the zygomatic arch at a depth of 40–60 mm using
2 MHz probes. After optimising the Doppler signal by
standard methods, the probe was stabilised in a fixed
position using a headband. Expiratory air was sampled via a
nasal cannula and end-tidal CO2 (PETCO2) measured by
infrared absorption (Colin Pilot; Colin Medical).
Data analysis All data were digitised using a custom-
made analogue-to-digital converter at a sampling rate of
300 Hz, fed to a microcomputer (Macintosh Powerbook;
Apple, Cupertino, CA, USA), and stored for off-line
analysis. The QRS complexes of the electrocardiogram
were identified using a C-language program. Beat-to-beat
mean values of RR intervals, mean arterial pressure and
CBFV were calculated automatically and interpolated
linearly between adjacent values to construct a corre-
sponding continuous time series. From the time series, data
segments of 90 s with the most stable PETCO2 values were
analysed.
Oscillations in mean arterial pressure, RR intervals and
CBFV were evaluated by autoregressive power spectrum
analysis. Dynamic cerebral autoregulation was determined
by using cross-spectral analysis to characterise the relation-
ship between breathing-induced oscillations in blood
pressure and CBFV. We calculated the gain and the phase
relationship between mean blood pressure and CBFV os-
cillations at 0.1 Hz to quantify the transmission of 0.1 Hz
breathing-induced blood pressure oscillations onto the
cerebral vasculature.
Statistical analysis All values are reported as mean±SEM.
Mean values of all the recorded signals, frequency-domain
responses and parameters of cerebral autoregulation were
compared between controls and patients using a two-sided
t test with Welch correction for independent samples.
Because of their skewed distributions, powers of RR
intervals, blood pressure and CBFV were analysed after
natural logarithmic transformation. Statistical significance
was accepted at p<0.05. Statistical tests were performed
using commercially available software (Instat version 3.01;
Graphpad Software, San Diego, CA, USA).
Results
Resting values of the cardiovascular variables recorded
during the baseline period are listed in Table 1. The basal
cardiovascular state was similar for patients and controls,
although the resting heart rate tended to be slightly higher
in the patients than in the control participants.
Each of the diabetic patients and healthy controls was
able to perform the slow breathing test at six breaths per
minute. Slow breathing at 0.1 Hz induced oscillations at
0.1 Hz in RR interval, blood pressure and CBFV in all
controls and patients. End-tidal CO2 levels during deep
breathing were 32.1±1.7 mmHg in the controls and
32.2±2.9 mmHg in the patients (p=0.98). Figure 1 shows
the power of breathing-induced breathing oscillations in RR
interval at 0.1 Hz. In the diabetic patients, RR interval
variability at 0.1 Hz during 0.1 Hz breathing was
significantly less than in the control participants (p<0.01).
The powers of mean blood pressure and CBFV variabilities
at 0.1 Hz during slow breathing are shown in Fig. 2.
Although the power of breathing-induced 0.1 Hz mean blood
pressure oscillations was slightly greater in the controls than
in the patients, the difference was not significant (p=0.39).
Table 1 Baseline cardiovascular parameters in controls and patients
with type 2 diabetes
Parameter Controls Diabetic patients p value
(n=11) (n=10)
Heart rate (beats per min) 63±3 73±4 0.10
Systolic blood pressure
(mmHg)
130±5 127±6 0.73
Diastolic blood pressure
(mmHg)
74±3 72±2 0.74
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Fig. 1 Powers of low-frequency variability in RR interval (RRI)
during slow breathing at 0.1 Hz in the 11 healthy controls and ten
diabetic patients. Values are means±SEM. The variability of RRI was
significantly less in the patients than in the controls (**p<0.01)
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There was also no difference in the power of slow breathing-
induced 0.1 Hz CBFV oscillations between the controls and
patients (p=0.87). Cross-spectral analysis revealed that the
gain between 0.1 Hz oscillations between blood pressure and
CBFV was not significantly different (p=0.13) between
the controls (0.79±0.07 cm s−1 mmHg−1) and patients
(1.10±0.18 cm s−1 mmHg−1). In all controls and patients,
cerebral blood flow oscillations showed a positive phase
shift in relation to the blood pressure oscillations. The phase
shift between 0.1 Hz blood pressure and CBFV oscillations
was, however, significantly lower in the patients than in the
controls (Fig. 3). There was no correlation between the phase
shift and RR interval variability during deep breathing.
Discussion
Although several techniques are available for assessment of
cerebral autoregulation, some are unsuitable for routine
clinical use because they are too cumbersome, require special
equipment or involve discomfort to the patient. In the present
study we evaluated the slow breathing technique, introduced
byDiehl et al. [12], as a clinical test of cerebral autoregulation
in patients with type 2 diabetes. We found that all patients
and controls were able to maintain the slow breathing
frequency of six breaths per minute, which induced 0.1 Hz
fluctuations in blood pressure that were transferred onto the
CBFV. In the healthy controls, the CBFVoscillations showed
a positive phase shift, i.e. to the left of blood pressure
oscillations, by about 80°. In the type 2 diabetic patients the
phase shift of the oscillations in CBFV was substantially
lower, indicating altered cerebral autoregulation.
Blood pressure oscillations induced by breathing are
predominantly due to the mechanical effects of fluctuations
in cardiac stroke volume [14]. Slow breathing at six cycles
per minute (0.1 Hz) generates oscillations in blood pressure
at the same frequency that are transmitted onto the CBFV
[12]. Because the mechanisms of cerebral autoregulation
resemble a high-pass filter, the resulting CBFV oscillations
are shifted to the left [12]. This phase shift can be explained
by the time lag with which the cerebrovascular resistance
vessels respond to changes in cerebral perfusion pressure
[15]. Diehl et al. [12] demonstrated that healthy individuals
had a phase shift of approximately 70°, with a lower normal
limit of 30°. In contrast, in patients with disturbed cerebral
autoregulation the phase shift was considerably reduced [12].
In our diabetic patients the phase shift between 0.1 Hz
breathing-induced oscillations in blood pressure and CBFV
was less than in the healthy controls, suggesting a slower
adaptation of the cerebral resistance vessels and impairment
of autoregulation. On an individual basis, three of our
diabetic patients but none of our healthy controls had phase
shift values that were less than the lower normal limit (30°)
that was previously defined by Diehl et al. [12]. Further-
more, four of our patients (40%) had values that were less
than the lowest value that we measured in our healthy
controls. These findings are in line with our previous
observation that the phase shift between blood pressure and
CBFV was reduced in type 2 diabetic patients during
carotid baroreceptor stimulation using neck suction [11].
One limitation of that study was that, due to baroreflex
dysfunction, carotid baroreceptor stimulation did not
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Fig. 2 Powers of low-frequency (0.1 Hz) variability (mean±SEM) in
a mean blood pressure (MBP) and b CBFV during slow breathing at
0.1 Hz in the 11 healthy controls and ten diabetic patients. There were
no significant differences between controls and patients in the
variability of either mean blood pressure or cerebral blood flow
velocity
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Fig. 3 Individual and mean±SEM phase shift angles between
breathing-induced 0.1 Hz mean blood pressure (MBP) and CBFV
oscillations in the 11 healthy controls and ten diabetic patients. The
phase shift was significantly reduced in patients (*p<0.05) compared
with controls, indicating altered cerebral autoregulation
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stimulate fluctuations in blood pressure in the diabetic
patients. The lack of blood pressure change (the input to
cerebral autoregulation) during neck suction complicates
interpretation of the results. Our current approach avoids
this problem because the blood pressure oscillations gen-
erated by breathing are largely mechanical, rather than
reflex, in origin. It is therefore possible to induce blood
pressure oscillations in diabetic patients, even if they have
cardiovascular autonomic dysfunction. Further advantages
of the slow breathing method for assessing autoregulation
are that it is simple, does not require highly specialised
equipment and depends only on the patients’ ability to
regulate their breathing for only a few minutes. The tech-
nique is therefore ideally suited as a clinical test of cerebral
autoregulation in diabetic patients.
The gain between 0.1 Hz oscillations in blood pressure and
CBFV was similar in our diabetic patients and controls.
Overall dampening of 0.1 Hz breathing-induced blood
pressure fluctuations onto the cerebral vasculature did not,
therefore, appear to be impaired in the diabetic patients. Thus,
the autoregulatory disturbances in our patients were relatively
subtle. Previous studies have also reported relatively mild
alterations in cerebral blood flow autoregulation in patients
with diabetes [16, 17]. In some diabetic patients, impaired
autoregulation might contribute to orthostatic hypotension
[9], which is a known risk factor for ischaemic stroke [18].
Studies suggest that assessment of cerebral autoregulation
can identify patients with increased risk of stroke [19, 20].
Diagnosis of autoregulatory disturbances in patients with
diabetes is therefore particularly important, even in the early
stages of the disease. While our deep breathing method is
able to identify altered cerebral autoregulation in diabetic
patients, there is a clear need for larger-scale studies that
compare our technique with neuroimaging techniques such
as magnetic resonance imaging, perfusion positron emission
tomography and transcranial B-mode ultrasound examina-
tions, to determine whether altered phase shifts precede,
parallel or correlate with neuroimaging signs of diabetic
cerebrovascular complications.
Several factors probably contribute to impaired auto-
regulation in type 2 diabetic patients. The presence of
vascular abnormalities in diabetes is well established and is
characterised by increased vascular permeability [21],
endothelial dysfunction [22] and capillary basement mem-
brane thickening [23]. Many diabetic patients also have
autonomic dysfunction, affecting sympathetic and parasym-
pathetic regulation of the cardiovascular system [24]. Sev-
eral of our patients had cardiovascular autonomic neuropathy
as determined using standard tests of autonomic function.
Furthermore, heart rate variation during 0.1 Hz breathing was
markedly reduced in our diabetic patients compared with the
controls, suggesting impaired parasympathetic regulation.
The role of the autonomic nervous system in cerebral
autoregulation is, however, controversial [25, 26]. Studies in
animals suggest that parasympathetic activation results in
cerebrovascular vasodilatation [27]. In the present study
there was no correlation between heart rate variability during
deep breathing (an index of parasympathetic function) and
the phase relation between mean blood pressure and CBFV.
Nevertheless, we cannot exclude autonomic dysfunction as a
possible contributor to impaired autoregulation in our
diabetic patients.
An important methodological point concerns the use of
transcranial Doppler for measurements of cerebral blood
flow. Changes in CBFV reflect changes in cerebral blood
flow only if the diameter of the insonated artery remains
constant. There is considerable experimental data suggest-
ing that the diameter of the mid-cerebral artery remains
stable during rapid alterations in arterial pressure [28] and
during orthostatic stress [29]. We are therefore confident
that the changes in CBFV that we measured reflect actual
changes in cerebral blood velocity and were not influenced
by changes in the diameter of the insonated artery.
Our findings suggest that patients with type 2 diabetes
have subtle disturbances in cerebral autoregulation that can
be identified by measuring fluctuations in blood pressure
and CBFV during a deep breathing test. Long-term clinical
studies are required to determine the progression of
autoregulatory disturbances and their potential link to the
heightened risk of stroke in diabetic patients.
Duality of interest The authors declare that there is no duality of
interest associated with this manuscript.
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